| Serial Number | 79225147 |
| Word Mark | ASCENDIS PHARMA |
| Filing Date | Wednesday, October 11, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 1, 2022 |
| Registration Number | 6630735 |
| Registration Date | Tuesday, February 1, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 16, 2021 |
| Description of Mark | The mark consists of the turquoise word "ASCENDIS" under which is the grey word "PHARMA" next to a polygon broken by a white curved band in which the top is turquoise and the bottom is blue. |
| Goods and Services | Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides |
| Indication of Colors claimed | The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark. |
| Goods and Services | Licensing of industrial property; legal services |
| Disclaimer with Predetermined Text | "PHARMA" |
| Goods and Services | Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 19, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 19, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 19, 2018 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ascendis Pharma A/S |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | DK-2900 Hellerup DK |
| Party Name | Ascendis Pharma A/S |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DK-2900 Hellerup DK |
| Party Name | Ascendis Pharma A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DK-2900 Hellerup DK |
| Event Date | Event Description |
| Monday, August 1, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, July 13, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, July 13, 2022 | FINAL DISPOSITION PROCESSED |
| Sunday, May 1, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, February 1, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Friday, December 24, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, November 23, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 16, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 16, 2021 | PUBLISHED FOR OPPOSITION |
| Thursday, October 28, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, October 27, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, October 27, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 27, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 13, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 12, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 12, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, July 9, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, July 9, 2021 | FINAL REFUSAL E-MAILED |
| Friday, July 9, 2021 | FINAL REFUSAL WRITTEN |
| Thursday, June 10, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, March 16, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 15, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 15, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 15, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, March 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, March 15, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, March 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, March 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, March 15, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, March 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, March 15, 2021 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Monday, March 15, 2021 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, March 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, March 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, September 14, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 14, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, September 14, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, June 18, 2020 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Wednesday, June 3, 2020 | ASSIGNED TO LIE |
| Thursday, November 21, 2019 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, July 5, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, June 19, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 19, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Thursday, May 9, 2019 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, October 19, 2018 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, October 19, 2018 | LETTER OF SUSPENSION E-MAILED |
| Friday, October 19, 2018 | SUSPENSION LETTER WRITTEN |
| Monday, October 1, 2018 | DATA MODIFICATION COMPLETED |
| Friday, September 28, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 27, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 27, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 14, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, September 14, 2018 | NON-FINAL ACTION E-MAILED |
| Friday, September 14, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, August 17, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 17, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 16, 2018 | ASSIGNED TO LIE |
| Thursday, July 26, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 24, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 24, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, March 2, 2018 | REFUSAL PROCESSED BY IB |
| Friday, February 9, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, February 9, 2018 | REFUSAL PROCESSED BY MPU |
| Wednesday, February 7, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, February 6, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, February 2, 2018 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Tuesday, January 30, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, January 29, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 23, 2018 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 19, 2018 | ASSIGNED TO EXAMINER |
| Friday, January 19, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, January 18, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |